Prenetics raises $10M to popularize patient DNA testing in Asia

 Prenetics, a Hong Kong-based medical technology company, has raised a $10 million Series A round for its DNA testing technology that helps doctors provide more accurate diagnoses and better understand their patients. Read More
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.